Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 38

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 38
---
 regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

| ● | pertain to                                                                                                                         
 the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets 
 of the Company;                                                                                                                    |

| ● | provide reasonable assurance                                                                                                               
 that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting 
 principles and that receipts and expenditures of the Company are being made only in accordance with authorizations of management           
 and/or directors of the Company; and                                                                                                       |

| ● | provide reasonable assurance                                                                                                
 regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could 
 have a material effect on the financial statements.                                                                         |

Our internal controls may be inadequate or ineffective, which could cause financial reporting to be unreliable and lead to misinformation being disseminated to the public. Investors relying upon this misinformation may make an uninformed investment decision.

<div align='center'>21</div>

Failure to achieve and maintain an effective internal control environment could cause us to face regulatory action and also cause investors to lose confidence in our reported financial information, either of which could have a material adverse effect on the Company’s business, financial condition, results of operations and future prospects.

However, our auditors will not be required to formally attest to the effectiveness of our internal control over financial reporting pursuant to Section 404 until we are no longer an “emerging growth company” as defined in the JOBS Act if we take advantage of the exemptions available to us through the JOBS Act.

The costs of being an SEC-reporting public company could result in us being unable to continue as a going concern.

As an SEC-reporting public company, we will be required to comply with numerous financial reporting and legal requirements, including those pertaining to audits and internal control. The costs of maintaining a public company reporting requirements could be significant and may preclude us from seeking financing or equity investment on terms acceptable to us and our stockholders. We estimate these costs to be in excess of $100,000 per year and may be higher if our business volume or business activity increases significantly. Our current estimate of costs does not include the necessary expenses associated with compliance, documentation and specific reporting requirements of Section 404 as we will not be subject to the full reporting requirements of Section 404 until we exceed $700 million in market capitalization or we decide to opt-out of the “emerging growth company”